IP Verse

Immunogenic Mutant Peptide Screening Platform

PatentPatent Analysis

EP3194970

F HOFFMANN LA ROCHE
Application Number
EP15772084A
Filing Date
Sep 10, 2015
Status
Granted And Under Opposition
Jun 25, 2021
Grant Date
Jul 28, 2021
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP2464725B2
EP3559248B2
EP2296728B2

Bibliography

The patent EP3194970B1 was granted to F Hoffmann LA Roche on Jul 28, 2021 following the initial filing on Sep 10, 2015 under the application number EP15772084A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

BISCHOF & PARTNER RECHTSANWALTE PARTNERSCHAFTSGESELLSCHAFT MBBApr 27, 2022WITHDRAWN

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents